Tech Company Financing Transactions
Mondego Bio Funding Round
Mondego Bio, based in Cantanhede, secured investment capital from OrbiMed and Torrey Pines Investment.
Transaction Overview
Company Name
Announced On
9/18/2025
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
OrbiMed (Iain Dukes)
Torrey Pines Investment (Nikolay Savchuk)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Parque Tecnológico de Cantanhede, Núcleo 4, Lote 8
Cantanhede, 3060-197
Portugal
Cantanhede, 3060-197
Portugal
Phone
Website
Email Address
Overview
Headquartered in Portugal's main biotech park, Biocant, Mondego Bio is developing best-in-class Protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nikolay Savchuk
Browse more venture capital transactions:
Prev: 9/18/2025: WeaveGrid venture capital transaction
Next: 9/18/2025: EvoluteIQ venture capital transaction
Share this article
News on VC Transactions
We document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs